Skip to main content
Log in

Case Report: Highly Active Antiretroviral Therapy Leading to Resolution of Porphyria Cutanea Tarda in a Patient with AIDS and Hepatitis C

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. Wissel PS, Sordillo P, Anderson KE, Sassa S, Savillo RL, Kappas A: Porphyria cutanea tarda associated with the acquired immune deficiency syndrome. Am J Hematol 25:107–113, 1987

    Google Scholar 

  2. McAlister F, McClean K, Hamilton PG, Houston S: Human immunodeficiency virus infection and porphyria cutanea tarda: Coexistance of risk factors or causative association? Clin Infect Dis 20:348–351, 1995

    Google Scholar 

  3. Nomura N, Zolla-Pazner S, Simberkoff M, Kim M, Sassa A, Lim HW: Abnormal serum porphyrin levels in patients with the acquired immunodeficiency syndrome with or without hepatitis C virus infection. Arch Dermatol 32:906–910, 1996

    Google Scholar 

  4. O'Connor W, Murphy GM, Darby C, Fogarty J, Mulcahy F, O'Moore R, Barnes L: Porphyrin abnormalities in acquired immunodeficiency syndrome. Arch Dermatol 132:1443–1447, 1996

    Google Scholar 

  5. Cribier B, Rey D, Uhl G, Le Coz C, Hirth C, Libbrecht E, Vetter D, Lang JM, Stoll-Keller F, Grosshans E: Abnormal urinary coproporphyrin levels in patients infected by hepatitis C virus with or without human immunodeficiency virus. A study of 177 patients. Arch Dermatol 132:1448–1452, 1996

    Google Scholar 

  6. Elder GH: Porphyria cutanea tarda. Semin Liver Dis 18:67–75, 1998

    Google Scholar 

  7. Reynaud P, Goodfellow K, Svec F: Porphyria cutanea tarda as initial presentation of the acquired immunodeficiency syndrome in two patients. J Infect Dis 161:1032–1033, 1990 ( letter)

    Google Scholar 

  8. Blauvelt A: Hepatitis C virus and human immunodeficiency virus infection can alter porphyrin metabolism and lead to porphyria cutanea tarda. Arch Dermatol 132:1503–1504, 1996 (editorial)

    Google Scholar 

  9. Siegel LB, Eber BB: Porphyria cutanea tarda remission. Ann Intern Med 121:308–309, 1994 ( letter)

    Google Scholar 

  10. Sheikh MY, Wright RA, Burruss JB: Dramatic resolution of skin lesions associated with porphyria cutanea tarda after interferon-alpha therapy in a case of chronic hepatitis C. Dig Dis Sci 43:529–533, 1998

    Google Scholar 

  11. Herranz MT, El Amrani A, Aranegui P, Jimenez-Alonso JF, Rodenas JM, Vivaldi RM: Porphyria cutanea tarda and acquired immunodeficiency syndrome: Pathogenetic implications. Arch Dermatol 127:1585–1586, 1991 ( letter)

    Google Scholar 

  12. Castanet J, Lacour JP, Bodokh J, Bekri S, Ortonne JP: Porphyria cutanea tarda in association with human immunodeficiency virus infection: Is it related to hepatitis C virus infection? Arch Dermatol 130:664–665, 1994

    Google Scholar 

  13. Rutschmann OT, Hirschel B, Negro F, Perrin LH: Lack of effect of long-term HAART on hepatitis C (HCV) viremia. In Conference record of the 12th World AIDS Conference. Geneva, Marathon Multimedia, 1998, pp 309–310 (abstract no 22238)

  14. Blauvelt A, Harris HR, Hogan DJ, Jimenez-Acosta F, Ponce I, Pardo RJ: Porphyria cutanea tarda and human immunodeficiency virus infection. Int J Dermatol 31:474–479, 1992

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rich, J.D., Mylonakis, E., Nossa, R. et al. Case Report: Highly Active Antiretroviral Therapy Leading to Resolution of Porphyria Cutanea Tarda in a Patient with AIDS and Hepatitis C. Dig Dis Sci 44, 1034–1037 (1999). https://doi.org/10.1023/A:1026681218915

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026681218915

Navigation